Showing 20 of 162 recruiting trials for “nasopharyngeal-carcinoma”
Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer
RecruitingNCT07050576 ↗
Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
Myosteatosis in Oeso-gastric Cancer: Clinical Impacts
👨⚕️ Yannick Deswysen, MD, Cliniques universitaires Saint-Luc- Université Catholique de Louvain📍 1 site📅 Started May 2024View details ↗
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
👨⚕️ Hecheng Li, MD/PHD, Ruijin Hospital Shanghaijiaotong University School of Medicine📍 1 site📅 Started May 2024View details ↗
A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer
RecruitingNCT06361043 ↗
Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC)
👨⚕️ Hossein Hemmatazad, MD, Inselspital Bern, Department of Radio-Oncology📍 1 site📅 Started Apr 2024View details ↗
Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Predicting Esophageal Cancer Borders Using PET-Imaging
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
👨⚕️ Pin-I Huang, Ph.D, Taipei Veterans General Hospital, Taiwan📍 1 site📅 Started Feb 2024View details ↗
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
👨⚕️ Jingao Li, MD, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital📍 1 site📅 Started Feb 2024View details ↗
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
👨⚕️ Jing Huang, Ph.D, Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Feb 2024View details ↗
A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
RecruitingNCT06307314 ↗
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
👨⚕️ Jian Guan, Ph.D., Nanfang Hospital, Southern Medical University📍 5 sites📅 Started Feb 2024View details ↗
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
👨⚕️ Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Feb 2024View details ↗
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
RecruitingNCT06321939 ↗
Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)
The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →